Rational use of opioids for management of chronic nonterminal pain

American Family Physician

Volumn 86, Issue 3, 2012, Pages 252-258

  Berland, Daniel ^a   Rodgers, Phillip ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; BUPRENORPHINE; CARBAMAZEPINE; CLONIDINE; DESIPRAMINE; DOXEPIN; DULOXETINE; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; LAMOTRIGINE; METHADONE; MILNACIPRAN; MORPHINE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PARACETAMOL; PREGABALIN; STEROID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CHRONIC PAIN; CLINICAL DECISION MAKING; CONSTIPATION; DEPRESSION; DROWSINESS; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG MISUSE; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; MAINTENANCE THERAPY; MASS SPECTROMETRY; MASSAGE; NAUSEA; PATIENT SAFETY; PATIENT SELECTION; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PRESCRIPTION; PRURITUS; QUALITY OF LIFE; REVIEW; TRANSCUTANEOUS NERVE STIMULATION; URINALYSIS; WEIGHT CONTROL;

EID: 84864677571     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507-513.
2. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109(3):514-519.
3. Chapman CR, Lipschitz DL, Angst MS, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain. 2010;11(9):807-829.
4. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174(11):1589-1594.
5. Seehusen DA. Opioid therapy for chronic noncancer pain. Am Fam Physician. 2010;82(1):40.
6. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1):CD006605.
7. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91(2):199-211.
8. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24(6):479-496.
9. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104(3):570-587.
10. Jensen MK, Thomsen AB, Højsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur J Pain. 2006;10(5):423-433.
11. Saper JR, Lake AE III, Bain PA, et al. A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring. Headache. 2010;50(7):1175-1193.
12. Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010;59(23):705-709.
13. Agency Medical Directors' Group. Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010. http://www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf. Accessed September 26, 2011.
14. U.S. Food and Drug Administration. FDA acts to reduce harm from opioid drugs. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm251830.htm. Accessed September 26, 2011.
15. University of Michigan Health System. Managing chronic non-terminal pain in adults including prescribing controlled substances. http://www.med.umich.edu/1info/FHP/practiceguides/pain/pain.pdf. Accessed September 26, 2011.
16. Brookoff D. Chronic pain: 1. A new disease? Hosp Pract (Minneap). 2000;35(7):45-52, 59.
17. Clauw DJ. Fibromyalgia: an overview. Am J Med. 2009;122(12 suppl):S3-S13.
18. Chou R, Fanciullo GJ, Fine PG, et al.; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
19. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107-112.
20. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454.
21. Kindler LL, Sibille KT, Glover TL, Staud R, Riley JL III, Fillingim RB. Drug response profiles to experimental pain are opioid and pain modality specific. J Pain. 2011;12(3):340-351.
22. Hanks GW. Opioid-responsive and opioid-non-responsive pain in cancer. Br Med Bull. 1991;47(3):718-731.
23. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432-442.
24. Devulder J, Jacobs A, Richarz U, Wiggett H. Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Br J Anaesth. 2009;103(4):576-585.
25. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians [published correction appears in Mayo Clin Proc. 2008;83(7):851]. Mayo Clin Proc. 2008;83(1):66-76.
26. Heit HA, Gourlay DL. Buprenorphine: new tricks with an old molecule for pain management [published correction appears in Clin J Pain. 2008;24(4):370]. Clin J Pain. 2008;24(2):93-97.
27. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315-1321.
28. Nilsen HK, Stiles TC, Landrø NI, Fors EA, Kaasa S, Borchgrevink PC. Patients with problematic opioid use can be weaned from codeine without pain escalation. Acta Anaesthesiol Scand. 2010;54(5):571-579.